Cambio de paradigma en el EGFR mutado: desde las primeras mutaciones a las de resistencia - page 7

Slow PD: continue EGFR-TKI
“Slow PD” should be defined
Asymptomatic pts with no new lesions?
Continuing EGFR-TKI in “Slow PD” is based on clinical
experience
Delays the use of 2
nd
-line therapy
In individual cases, local therapy can improve disease control
1,2,3,4,5,6 8,9,10,11,12,13,14,15,16,17,...35
Powered by FlippingBook